Our Mission at Hyperion Therapeutics

Revolutionize the standard of care to combat our world's leading causes of blindness:

๐Ÿ‘ย  Age-related Macular Degeneration (AMD)

๐Ÿ‘ย  Diabetic Retinopathy (DR)

๐Ÿ‘ย  Retinitis Pigmentosa (RP)

๐Ÿ‘ย  Glaucoma

๐Ÿ‘ย  and more...

An urgent, unmet medical need

Prioritizing new medications to effectively preserve eyesight in the most common age-related and inherited retinal diseases, impacting over 420 million patients worldwide.

A new class of therapeutics in SREDs

Pioneering "Stress Resilience-Enhancing Drugs" (SREDs) โ€“ a novel, multi-targeted therapeutic strategy, for the treatment of neurodegenerative conditions, to restore homeostasis among multiple cell types implicated in disease.